Physician profile
Spencer Lee
NPI 1831415157
$8,215.21
in general payments reported to CMS, 2019-2025
44 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $519 · 2021: $423 · 2022: $1,185 · 2023: $3,277 · 2024: $910 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,157 · Food and Beverage: $2,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,157.43 |
| Food and Beverage | $2,135.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,587.08 | 2022-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $855.48 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $410.68 | 2019-2022 | |
| Genzyme Corporation | $381.28 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $350.81 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $335.45 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Grifols USA, LLC | $219.14 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $205.67 | 2019-2024 | Smartvest |
| Mylan Specialty L.P. | $169.05 | 2019-2024 | Yupelri |
| Abiomed | $136.57 | 2024 | Impella |
| Pfizer INC. | $125.64 | 2022-2025 | |
| Insmed, INC. | $118.34 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $111.34 | 2020-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $100.19 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.10 | 2024-2025 | Glassia |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $72.63 | 2019 | |
| Verona Pharma, INC. | $68.45 | 2025 | Ohtuvayre |
| Philips North America LLC | $65.70 | 2019-2022 | |
| Viatris Specialty LLC | $62.35 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Inspire Medical Systems, INC. | $56.11 | 2024-2025 | Inspire |
| Merck Sharp & Dohme LLC | $54.59 | 2021-2025 | Winrevair |
| Portola Pharmaceuticals, LLC | $53.43 | 2019-2020 | |
| Vapotherm INC | $50.80 | 2022 | |
| Eisai INC. | $34.96 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $34.74 | 2022 | |
| Baxter Healthcare | $34.73 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Inari Medical, INC. | $33.32 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $33.06 | 2024 | Flexitouch Plus, Entre Plus |
| Alexion Pharmaceuticals, INC. | $27.60 | 2021 | |
| Axsome Therapeutics, INC. | $24.87 | 2025 | Sunosi |
| Amgen INC. | $22.74 | 2025 | Tezspire |
| Ethicon INC. | $22.70 | 2019 | |
| Advanced Respiratory, INC | $22.39 | 2019 | |
| La Jolla Pharmaceutical Company | $21.06 | 2020 | |
| Shire North American Group INC | $20.27 | 2019 | |
| Ani Pharmaceuticals, INC. | $20.13 | 2024 | Purified Cortrophin Gel |
| Pulmonx Corporation | $19.27 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Allergan, INC. | $18.53 | 2019 | |
| United Therapeutics Corporation | $16.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.81 | 2020 | |
| Galvanize Therapeutics, INC | $15.15 | 2024 | Aliya System |
| Mallinckrodt Enterprises LLC | $15.13 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.